EQT

EQT Partners AB is a private equity and venture capital firm based in Stockholm, Sweden, with a global presence through additional offices in major cities across Europe, Asia, and North America. Founded in 1994, EQT specializes in a wide array of investment strategies, including expansion capital, buyouts, and growth equity, focusing on medium to large-sized companies with consistent cash flows or significant intrinsic value. The firm targets various sectors, such as healthcare, technology, energy, and infrastructure, and emphasizes investments in mid-market situations, over-leveraged companies, and distressed assets. EQT's investment approach is characterized by taking controlling or co-controlling equity stakes in its portfolio companies and actively participating in their management, often securing board seats. The firm typically holds investments for four to eight years, aiming to enhance growth and create long-term value for stakeholders.

Andreas Aschenbrenner

Partner

Fouad Azzam

General Partner

Peter Balslev

Managing Director

Gregory Bernstein

Associate

Lennart Blecher

Deputy Managing Partner

Clemens van Blitterswijk

Founder of LSP Health Economics Fund

Carolina Brochado

Partner

Brian Chang

Partner

Hans Clevers

Venture Partner

Rudy Dekeyser

Co-Founder Managing Director

Johan Dettel

Partner

Christina Drews

COO and Executive Committee

Victor Englesson

Partner

Stephen Escudier

Partner

Andreas Fischer

Partner

Fabian Grone

Partner, Head of Asia

Andreas Huber

Partner

Lars Jörnow

Partner

Kasper Grundtvig Knokgaard

Partner

John de Koning

General Partner

Kees Koolen

Partner

Ulrich Kollensperger

Partner

Nicholas Macksey

Partner

Robert Maclean

Partner

Martin Mix

Managing Director

Joep Muijrers

General Partner

Jörg Neermann

Partner

Suzana Peric

Director

Anne Portwich

Partner

Johannes Reichel

Partner

Carl Johan Renstrom

Partner

Niklas Ringby

Partner

Darlene Sammon

Partner

Carlos Santana

Partner

Christian Sinding

Managing Partner and CEO

Jan Stypulkowski

Managing Director

Jan Vesely

Partner

Fabian Wasmus

Partner

Mark Wegter

Managing Partner

Matthias Wittkowski

Partner

Fredrik Atting

Partner

Past deals in Adriatic

OX2

Acquisition in 2024
OX2 is a company focused on providing renewable energy solutions, including the development and sale of wind and solar farms. They operate in several countries across Europe, such as Sweden, Finland, Poland, France, Lithuania, Norway, Spain, Italy, Estonia, and Romania. In addition to their core activities in solar and onshore and offshore wind farms, OX2 is also involved in energy storage projects and the development of hydrogen solutions. The company emphasizes technical and business management solutions to support its various energy initiatives.

Casa.it

Acquisition in 2020
Casa.it S.r.l. is an online property portal based in Milan, Italy, that has been operational since 1996. The company specializes in providing advertising services for real estate, offering a comprehensive platform for users to access information on real estate agencies, as well as properties available for sale or rent. This includes a diverse range of listings such as flats, villas, independent houses, penthouses, and lofts. Casa.it serves as a vital resource for individuals seeking residential options, facilitating connections between property seekers and real estate professionals in Italy.

Idealista

Acquisition in 2020
Idealista operates an online property portal that serves agents and private individuals in Spain, Italy, and Portugal. The platform functions as a digital real estate marketplace, providing buyers and sellers with essential real-time information to facilitate property transactions. By offering a user-friendly interface, Idealista helps alleviate the challenges associated with finding a home, thus supporting millions of users in their real estate endeavors. Additionally, the company allows property owners to advertise their listings through a subscription model, enabling them to reach a broader audience while accessing valuable market insights.

Groupe Colisée

Acquisition in 2020
Colisée is a key player in the global health care and old-age dependency sector, and has developed a real expertise in elderly people care and well-being. Its network includes 90 facilities in France, Italy and Spain and close to 70 home-based services agencies in France. In those two business segments, Colisée employs more than 6,700 people.

Facile.it

Acquisition in 2018
Facile.it is an online price comparison platform based in Milan, Italy, that helps users compare prices and services across various sectors, including insurance, energy, telecommunications, loans, and banking. By leveraging technology, Facile.it enables clients to identify the best offers available in the market, allowing them to make informed decisions and achieve significant savings on their expenses. The platform is designed to streamline the comparison process, ultimately saving users time and effort as they seek to optimize their financial choices.

Dentconnect

Acquisition in 2017
DentConnect is a fast-growing platform of dental clinics, with activities in the Netherlands, Belgium, Denmark, Germany and Italy. DentConnect is headquartered in the Netherlands and serves over one million patients through its pan-European network of over 220 clinics. DentConnect acts as a multi-functional service organization for these clinics, allowing the dentists to fully focus on providing patients with the best possible care. DentConnect Shared Service Center supports and facilitates dentists with HR, Finance and administration, quality and care management, procurement, marketing and communication and general management.

PharmaZell

Debt Financing in 2007
PharmaZell GmbH is a German company that specializes in the development and production of generic active pharmaceutical ingredients (API), controlled substances, and amino acids. Founded in 1947 and headquartered in Raubling, Germany, PharmaZell operates production facilities in Switzerland, Italy, and India, with a sales branch located in Cleveland, Ohio. The company serves the global pharmaceutical industry by providing custom synthesis, formulation development, and regulatory documentation services for both originator and generic pharmaceuticals. With a commitment to ethical practices and environmental responsibility, PharmaZell aims to be a reliable partner for its customers by offering tailored solutions and leveraging a flexible technology platform to address client needs efficiently.

Okairos

Series A in 2007
Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.